What is Insmed Inc (INSM)?

Insmed Inc (INSM) is a Stock on NASDAQ. This public tape shows delayed daily prices — not live quotes.

What is the ISIN of INSM?

The ISIN for Insmed Inc (INSM) is US4576693075. It trades on NASDAQ.

Is this live market data?

No. Tape shows delayed public daily prices. It is not investment advice. Live professional data is in the Stonks Ask terminal.

How do I research INSM in Stonks Ask?

Open the terminal and ask Stonks about INSM: business overview, recent price action, valuation, and what to watch next. Tape is the public delayed chart; the terminal adds live data and portfolio context.

INSM · Insmed Inc — Tape

All tape

I

INSM NASDAQ

Zacks.com published an article comparing prospects: 'Liquidia vs. Insmed: Which Pulmonary Stock Has Better Prospects Now?'. On the fundamentals side, Insmed Inc reported fiscal year revenue of 606,423,000, while operating with a market capitalization of approximately 27.37 billion. The company holds a TTM EPS of -4.027158710294821 alongside a price-to-earnings ratio of -30.727493917274938 and a free cash flow yield of -3.0601334553677546%.

Based on zacks.com

1D1 day

5D5 days

1M1 month

6M6 months

YTDYear to date

1Y1 year

5Y5 years

AllAll time

Market cap: 27.37B USD
Dividend yield: 0.00%
P/E: -30.73
Forward P/E: 125.41
Basic EPS (TTM): -4.03 USD
EPS (FY2027E): 0.96 USD
Net income (FY): -1.28B USD
Revenue (FY): 606.42M USD
Revenue (FY2027E): 2.89B USD
FCF yield (TTM): -3.06%
Shares float: —
Beta: —
52 week high
52 week low
Volume

Ticker: INSM
Exchange: NASDAQ
Type: Stock
Sector: —
ISIN: US4576693075

Revenue & Net Income (5Y)

EPS & Growth (5Y)

Free Cash Flow (5Y)

Capital Returns

Operating & Net Margin (5Y)

CapEx vs. Free Cash Flow (5Y)

Capital Allocation (5Y)

R&D and SG&A Intensity (5Y)

EBITDA (5Y)

Cost of Revenue (5Y)

Market Cap (5Y)

Ask Stonks with professional market data, charts beside chat, and your portfolio context.

Ask Stonks about INSM

Tape shows delayed public market data. Not investment advice.

INSM

I